Javascript must be enabled to continue!
Comparison of the planned one‐ and elective two‐stent techniques in patients with coronary bifurcation lesions with or without acute coronary syndrome from the COBIS II Registry
View through CrossRef
AbstractObjectivesTo evaluate the impacts of stent techniques on long‐term clinical outcomes after percutaneous coronary intervention (PCI) using drug‐eluting stents (DES) for coronary bifurcation lesions in patients with or without acute coronary syndrome (ACS).BackgroundFew studies have investigated the impacts of stent techniques for treating coronary bifurcation lesions in patients with and without ACS.MethodsThis multicenter registry enrolled 2,897 patients undergoing PCI with DES for coronary bifurcation lesions. We investigated the impacts of planned one‐stent and elective two‐stent techniques in patients with (n = 1,798) and those without (n = 1,099) ACS. Primary endpoint was the incidence of 3‐year target‐lesion failure (TLF), defined as a composite of cardiac death, spontaneous myocardial infarction, and target‐lesion revascularization.ResultsThe planned one‐stent technique reduced TLF rate compared to elective two‐stent technique in the ACS cohort (hazard ratio [HR] 0.49; 95% confidence interval [CI] 0.34–0.74; P = 0.001), and not in the non‐ACS cohort (HR 0.61; 95% CI 0.35–1.06; P = 0.079). After propensity score matching, the planned one‐stent technique had a significantly lower TLF rate (HR 0.47; 95% CI 0.29–0.74; P = 0.001) in patients with ACS, and it also showed a trend toward lower TLF rate with the planned one‐stent technique in patients without ACS (9.0 vs. 14.5%, HR 0.59; 95% CI 0.32–1.14; P = 0.116).ConclusionsPlanned one‐stenting reduced TLF in patients with ACS and it also might be beneficial in those without ACS for the treatment of coronary bifurcation lesions.
Title: Comparison of the planned one‐ and elective two‐stent techniques in patients with coronary bifurcation lesions with or without acute coronary syndrome from the COBIS II Registry
Description:
AbstractObjectivesTo evaluate the impacts of stent techniques on long‐term clinical outcomes after percutaneous coronary intervention (PCI) using drug‐eluting stents (DES) for coronary bifurcation lesions in patients with or without acute coronary syndrome (ACS).
BackgroundFew studies have investigated the impacts of stent techniques for treating coronary bifurcation lesions in patients with and without ACS.
MethodsThis multicenter registry enrolled 2,897 patients undergoing PCI with DES for coronary bifurcation lesions.
We investigated the impacts of planned one‐stent and elective two‐stent techniques in patients with (n = 1,798) and those without (n = 1,099) ACS.
Primary endpoint was the incidence of 3‐year target‐lesion failure (TLF), defined as a composite of cardiac death, spontaneous myocardial infarction, and target‐lesion revascularization.
ResultsThe planned one‐stent technique reduced TLF rate compared to elective two‐stent technique in the ACS cohort (hazard ratio [HR] 0.
49; 95% confidence interval [CI] 0.
34–0.
74; P = 0.
001), and not in the non‐ACS cohort (HR 0.
61; 95% CI 0.
35–1.
06; P = 0.
079).
After propensity score matching, the planned one‐stent technique had a significantly lower TLF rate (HR 0.
47; 95% CI 0.
29–0.
74; P = 0.
001) in patients with ACS, and it also showed a trend toward lower TLF rate with the planned one‐stent technique in patients without ACS (9.
0 vs.
14.
5%, HR 0.
59; 95% CI 0.
32–1.
14; P = 0.
116).
ConclusionsPlanned one‐stenting reduced TLF in patients with ACS and it also might be beneficial in those without ACS for the treatment of coronary bifurcation lesions.
Related Results
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...
P5637A novel bioresorbable magnesium-based stent: initial clinical results and 6-months follow-up by coronary computed tomography angiography scan
P5637A novel bioresorbable magnesium-based stent: initial clinical results and 6-months follow-up by coronary computed tomography angiography scan
Abstract
Background
Drug-eluting stents (DES) are the gold standard in percutaneous coronary interventions (PCI), but leave a pe...
Predictors of Side Branch Obstruction Following Stenting of the Main Vessel in Coronary Bifurcation Lesions
Predictors of Side Branch Obstruction Following Stenting of the Main Vessel in Coronary Bifurcation Lesions
INTRODUCTION: Percutaneous coronary intervention (PCI) of bifurcation lesions is complicated by the presence of side branch blockage, which contributes to a low procedural success ...
Ostial Right Coronary Artery Stent Loss, Stent-In-Stent Entrapment, and Subsequent Surgical Extraction
Ostial Right Coronary Artery Stent Loss, Stent-In-Stent Entrapment, and Subsequent Surgical Extraction
Abstract
Background:
Percutaneous coronary intervention of calcified coronary lesions is fraught with short-term and long-term risks. Judicious use of adjunct intracoronary...
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Predictors of insistent restenosis in patients undergoing percutaneous intervention
Coronary artery disease is one of the leading causes of morbidity and mortality worldwide. The first percutaneous coronary intervention was performed by Andreas Gruntzig on Septemb...
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
Minimum stent area, stent expansion and ultrasonic flow ratio post pci: insights from multivessel talent trial
Abstract
Background
Ultrasonic flow ratio (UFR) is a novel method for fast computation of fractional flow reserve (FFR) from int...
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Treatment of Bifurcation Coronary Artery Disease with the Dedicated Cappella Sideguard® Stent
Bifurcation coronary lesions represent a significant proportion of percutaneous coronary intervention (PCI) procedures and are often technically challenging with both lower procedu...
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...

